Latest filing published 06 May 2022 for Acerus Pharmaceuticals Corporation.
No signal scores available.
This profile gathers the share dealings of William Scott Leckie in Acerus Pharmaceuticals Corporation. Between 23 June 2020 and 6 May 2022, the trades on record add up to 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 6 May 2022, the filings show a transaction in Acerus Pharmaceuticals Corporation. Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations